European Cancer Organisation shared on LinkedIn:
“What should the EU Biotech Act deliver for people with cancer and rare diseases?
Join us on 12 October to find out.
Stine Bosse MEP will bring the political perspective to the dialogue, while Vittoria Carraro will discuss the challenges the Act seeks to address and its potential impact on research, innovation and patient access.
12 October, 15:45–17:30 CEST
European Parliament, Spinelli 5G1
Places are limited, and accreditation is required to access the European Parliament.
This also can be interesting:
Can the European Biotech Act Make Europe a Global Biotech Leader?
